GraniteShares Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$581K	Sell	1,755 -31	-2%	-$10.5K	0.42%	66
2025 Q4	$710K	Buy	1,786 +147	+9%	+$65.1K	0.43%	72
2025 Q3	$747K	Sell	1,639 -260	-14%	-$106K	0.43%	68
2025 Q2	$619K	Sell	1,899 -211	-10%	-$58.4K	0.38%	72
2025 Q1	$570K	Sell	2,110 -155	-7%	-$39.8K	0.36%	71
2024 Q4	$533K	Sell	2,265 -454	-17%	-$119K	0.34%	78
2024 Q3	$748K	Sell	2,719 -1,151	-30%	-$300K	0.51%	71
2024 Q2	$940K	Buy	3,870 +693	+22%	+$109K	0.31%	64
2024 Q1	$475K	Buy	3,177 +387	+14%	+$64.6K	0.25%	88
2023 Q4	$534K	Sell	2,790 -103	-4%	-$17.5K	0.48%	86
2023 Q3	$512K	Buy	+2,893	New	+$552K	0.48%	79
2022 Q1	–	Sell	-595	Closed	-$100K	–	173
2021 Q4	$100K	Buy	+595	New	+$111K	0.05%	270